Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)
Agency
National Institutes of Health
Posted
Nov 3, 2026
Due Date
Feb 17, 2028
Description
<p>This notice of funding opportunity (NOFO) encourages research focused on developing, optimizing, and testing the effectiveness of <span style="background-color:rgba(0,0,0,0);">service-ready, scalable strategies and tools that can be used to facilitate training (i.e., promote competence and sustained implementation fidelity) and quality monitoring in the delivery of evidence-based suicide prevention interventions </span>across the range of settings where at-risk individuals are encountered, and across intercepts in suicide prevention services. Relevant research focuses on (1) developing and testing scalable approaches, including technology-supported approaches, for training providers in evidence-based approaches for assessing and managing risk (e.g., prevention, treatment, and crisis services), and/or (2) developing and validating pragmatic strategies for monitoring the delivery and quality of suicide prevention services, to facilitate efforts at training, supervision, and quality improvement efforts. </p><p>In an effort to streamline the application process and sustain momentum in this critical research area, this NOFO supports both exploratory/developmental and standard research projects through a grant award instrument. </p>
AI Summary
Estimated Funding: 3,000,000 | Agency: National Institutes of Health
Details
- Notice ID
- 359019
- Solicitation Number
- RFA-MH-28-145
- Classification Code
- D
Want to track opportunities like this?
Sign up for Kontratar to get AI-powered opportunity matching, ranking, and alerts.
Get Started FreeRelated opportunities
- Leveraging NAMs to understand disease triggers, discover early biomarkers and develop new classes of therapeutic strategies for Type 1 Diabetes (U01 Clinical Trial Not Allowed)
National Institutes of Health
- Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
National Institutes of Health
- Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)
National Institutes of Health
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
- George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institutes of Health
- Single Source: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed)
National Institutes of Health